Clinical profile of patients with seronegative celiac disease.

Q3 Medicine
Elham Rahmanipour, Mohammad Ghorbani, Azita Ganji, Zahra Mirzaei, Vahid Ghavami, Bijan Shahbazkhani, Fahime Attarian, Masoumeh Amiri
{"title":"Clinical profile of patients with seronegative celiac disease.","authors":"Elham Rahmanipour, Mohammad Ghorbani, Azita Ganji, Zahra Mirzaei, Vahid Ghavami, Bijan Shahbazkhani, Fahime Attarian, Masoumeh Amiri","doi":"10.22037/ghfbb.v16i2.2756","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to determine the clinical profile of patients with seronegative celiac disease (SNCD).</p><p><strong>Background: </strong>Celiac disease (CD) is mainly diagnosed based on positive serology and duodenal mucosal atrophy, but some patients have negative serology. Their diagnosis has some limitations; delays in diagnosis are likely accompanied by a poor prognosis and a high risk of developing complications of CD.</p><p><strong>Methods: </strong>In this retrospective study, 1115 patients were evaluated for CD with mucosal atrophy between 2010 to 2020. SNCD diagnosis requires genetic CD predisposition and improvement of both clinical symptoms and regrowth of duodenal villi after 12 months of a gluten-free diet (GFD) for all patients with IgA deficiency, other IgG-based serology for diagnosis of celiac was done and if these antibodies were negative, consider them as possible SNCD. If they had positive DQ2-DQ8 and improvement of clinical symptoms and mucosal atrophy after 12 months of GFD were confirmed SNCD.</p><p><strong>Results: </strong>Of the 1115 study subjects, 27 had SNCD, 1088 had SPCD with a mean age of 29.7±15.7 years (1 to 76 years) in seropositive celiac disease (SPCD) subjects and 37.1±16.3 years (6 to 63 years) in SNCD participants and 19 female patients with SNCD were presented. The BMI of SNCD and SPCD patients were reported 23.9 and 21.4, respectively. In addition, SPCD subjects were more likely but not statistically significant to have a positive family history. Villous atrophy was shown in 100% SNCD and 95.6% SPCD cases. Scalloping and fissuring in duodenal biopsies were reported in 60% of SNCD and 84.5% of SPCD patients. There was some other cause of seronegative villous atrophy including 3 patients with Crohns disease, 2 with common variable immunodeficiency, 2 drug and one patient with peptic duodenitis. Anemia, neurological symptoms, and liver function tests (LFT) abnormality were common extra intestinal manifestations in SNCD individuals. Levels of Thyroid peroxidase (TPO), TSH were measured, it had been detected that SNCD cases had a higher rate of co-occurrence with thyroid diseases also SPCD cases showed a higher rate of co-occurrence with diabetes.</p><p><strong>Conclusion: </strong>Among patients with celiac disease 2.4% are SNCD. SNCD are older than SPCD at the time of diagnosis and have higher BMI. Most common of cause of seronegative enteropathy also is SNCD followed by inflammatory bowel disease (IBD) common variable immunodeficiency (CVID), medication use, and duodenitis, in this area.</p>","PeriodicalId":12636,"journal":{"name":"Gastroenterology and Hepatology From Bed to Bench","volume":"16 2","pages":"203-209"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/24/fb/GHFBB-16-203.PMC10404820.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastroenterology and Hepatology From Bed to Bench","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22037/ghfbb.v16i2.2756","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: This study aimed to determine the clinical profile of patients with seronegative celiac disease (SNCD).

Background: Celiac disease (CD) is mainly diagnosed based on positive serology and duodenal mucosal atrophy, but some patients have negative serology. Their diagnosis has some limitations; delays in diagnosis are likely accompanied by a poor prognosis and a high risk of developing complications of CD.

Methods: In this retrospective study, 1115 patients were evaluated for CD with mucosal atrophy between 2010 to 2020. SNCD diagnosis requires genetic CD predisposition and improvement of both clinical symptoms and regrowth of duodenal villi after 12 months of a gluten-free diet (GFD) for all patients with IgA deficiency, other IgG-based serology for diagnosis of celiac was done and if these antibodies were negative, consider them as possible SNCD. If they had positive DQ2-DQ8 and improvement of clinical symptoms and mucosal atrophy after 12 months of GFD were confirmed SNCD.

Results: Of the 1115 study subjects, 27 had SNCD, 1088 had SPCD with a mean age of 29.7±15.7 years (1 to 76 years) in seropositive celiac disease (SPCD) subjects and 37.1±16.3 years (6 to 63 years) in SNCD participants and 19 female patients with SNCD were presented. The BMI of SNCD and SPCD patients were reported 23.9 and 21.4, respectively. In addition, SPCD subjects were more likely but not statistically significant to have a positive family history. Villous atrophy was shown in 100% SNCD and 95.6% SPCD cases. Scalloping and fissuring in duodenal biopsies were reported in 60% of SNCD and 84.5% of SPCD patients. There was some other cause of seronegative villous atrophy including 3 patients with Crohns disease, 2 with common variable immunodeficiency, 2 drug and one patient with peptic duodenitis. Anemia, neurological symptoms, and liver function tests (LFT) abnormality were common extra intestinal manifestations in SNCD individuals. Levels of Thyroid peroxidase (TPO), TSH were measured, it had been detected that SNCD cases had a higher rate of co-occurrence with thyroid diseases also SPCD cases showed a higher rate of co-occurrence with diabetes.

Conclusion: Among patients with celiac disease 2.4% are SNCD. SNCD are older than SPCD at the time of diagnosis and have higher BMI. Most common of cause of seronegative enteropathy also is SNCD followed by inflammatory bowel disease (IBD) common variable immunodeficiency (CVID), medication use, and duodenitis, in this area.

血清阴性乳糜泻患者的临床概况。
目的:本研究旨在确定血清阴性乳糜泻(SNCD)患者的临床特征:背景:乳糜泻(CD)的诊断主要依据血清学阳性和十二指肠粘膜萎缩,但也有部分患者血清学阴性。他们的诊断有一定的局限性;延误诊断很可能会导致预后不良,并极有可能出现 CD 的并发症:在这项回顾性研究中,2010 年至 2020 年间对 1115 例 CD 伴粘膜萎缩患者进行了评估。SNCD的诊断需要遗传性CD易感性和临床症状的改善,以及所有患者在无麸质饮食(GFD)12个月后十二指肠绒毛的重新生长,并进行其他基于IgG的血清学检查以诊断乳糜泻,如果这些抗体呈阴性,则认为他们可能是SNCD。如果他们的 DQ2-DQ8 阳性,并且在 GFD 12 个月后临床症状和粘膜萎缩有所改善,则确认为 SNCD:在1115名研究对象中,27人患有SNCD,1088人患有SPCD,血清阳性乳糜泻(SPCD)患者的平均年龄为(29.7±15.7)岁(1至76岁),SNCD患者的平均年龄为(37.1±16.3)岁(6至63岁),其中有19名女性SNCD患者。据报告,SNCD 和 SPCD 患者的体重指数分别为 23.9 和 21.4。此外,SPCD 患者更有可能有阳性家族史,但无统计学意义。100%的SNCD病例和95.6%的SPCD病例出现绒毛萎缩。60%的SNCD患者和84.5%的SPCD患者的十二指肠活检组织出现扇形和裂纹。血清阴性绒毛萎缩还有一些其他原因,包括3名克罗恩病患者、2名常见变异性免疫缺陷患者、2名药物患者和1名消化性十二指肠炎患者。贫血、神经症状和肝功能检测(LFT)异常是SNCD患者常见的肠道外表现。通过测量甲状腺过氧化物酶(TPO)和促甲状腺激素(TSH)水平,发现SNCD病例合并甲状腺疾病的比例较高,SPCD病例合并糖尿病的比例也较高:结论:乳糜泻患者中有 2.4% 为 SNCD。结论:在乳糜泻患者中,有 2.4% 是 SNCD,SNCD 患者在确诊时比 SPCD 患者年龄更大,体重指数更高。在该地区,血清阴性肠病最常见的病因也是 SNCD,其次是炎症性肠病(IBD)、常见变异性免疫缺陷(CVID)、药物使用和十二指肠炎。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.30
自引率
0.00%
发文量
29
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信